Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Avoro Capital Advisors LLC (CIK 1633313) reported $10.16B across 27 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: UTHR ($1.57B, 15.44%), ASND ($1.16B, 11.39%), MDGL ($951.8M, 9.36%), KRYS ($746.3M, 7.34%), ARGX ($730.2M, 7.18%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP | $1.57B | 15.44% | 3.0M | Added |
| 2 | ASND | ASCENDIS PHARMA | $1.16B | 11.39% | 5.1M | Trimmed |
| 3 | MDGL | MADRIGAL PHARMACEUTICALS INC | $951.8M | 9.36% | 1.8M | Added |
| 4 | KRYS | KRYSTAL BIOTECH INC | $746.3M | 7.34% | 2.9M | Hold |
| 5 | ARGX | ARGENX SE | $730.2M | 7.18% | 1.0M | Added |
| 6 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $670.9M | 6.60% | 10.7M | Added |
| 7 | KYMR | KYMERA THERAPEUTICS INC | $622.6M | 6.12% | 7.5M | Hold |
| 8 | APLS | APELLIS PHARMACEUTICALS INC | $491.7M | 4.84% | 12.2M | Hold |
| 9 | CNTA | CENTESSA PHARMACEUTICALS PLC | $454.0M | 4.47% | 11.4M | Trimmed |
| 10 | CELC | CELCUITY INC | $388.3M | 3.82% | 3.6M | Added |
| 11 | XENE | XENON PHARMACEUTICALS INC | $336.0M | 3.31% | 5.8M | Added |
| 12 | GPCR | STRUCTURE THERAPEUTICS INC | $316.0M | 3.11% | 6.6M | Hold |
| 13 | TERN | TERNS PHARMACEUTICALS INC | $300.2M | 2.95% | 5.7M | Added |
| 14 | VERA | VERA THERAPEUTICS INC | $236.9M | 2.33% | 5.9M | Hold |
| 15 | RVMD | REVOLUTION MEDICINES INC | $228.0M | 2.24% | 2.3M | Added |
| 16 | CYTK | CYTOKINETICS INC | $219.7M | 2.16% | 3.3M | New |
| 17 | OCUL | OCULAR THERAPEUTIX INC | $104.3M | 1.03% | 12.3M | Added |
| 18 | GLTO | DAMORA THERAPEUTICS INC | $98.0M | 0.96% | 3.8M | New |
| 19 | QURE | UNIQURE NV | $97.4M | 0.96% | 6.0M | Trimmed |
| 20 | TSHA | TAYSHA GENE THERAPIES INC | $97.0M | 0.95% | 21.7M | Hold |
| 21 | DEFINIUM THERAPEUTICS INC | $94.5M | 0.93% | 5.0M | New | |
| 22 | SLNO | SOLENO THERAPEUTICS INC | $77.0M | 0.76% | 2.3M | Trimmed |
| 23 | ALKS | ALKERMES PLC | $42.4M | 0.42% | 1.2M | Trimmed |
| 24 | SEPN | SEPTERNA INC | $32.1M | 0.32% | 1.3M | Hold |
| 25 | VRDN | VIRIDIAN THERAPEUTICS INC | $29.3M | 0.29% | 1.5M | Hold |
Source: SEC Form 13F filings · as of 2026-03-31